EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping Review

Complete Freund’s adjuvant in laboratory animals: Reported welfare-relevant outcomes and alternatives—a scoping review

Valerie Hungerbühler iD, Agathe Verhulst iD, Cristian Berce iD, Otto Maissen, Beat Thomann iD, Luís Pedro Carmo iD

Laboratory Animals · 11.07.2026

DOI: 10.1177/00236772261459546 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Laboratory Animals, online erschienen am 11.07.2026. Verfasst von Valerie Hungerbühler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Public Health Institute, Vetsuisse Faculty, University of Bern, Switzerland. Die Arbeit nennt 67 Literaturangaben. Gefördert von: Swiss Federal Food Safety and Veterinary Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complete Freund’s adjuvant (CFA) is used in laboratory animals to stimulate strong immune responses. However, it can cause persistent local inflammation and tissue damage, raising welfare concerns. This scoping review aimed to (i) assess how frequently welfare-relevant outcomes are reported in CFA immunisation and antibody-production studies in mice, rats and rabbits; (ii) describe reported welfare-relevant outcomes and the methods used to assess them; (iii) chart CFA regimen details across studies; and (iv) summarise reported alternatives to CFA, including welfare comparisons where available. We followed a protocol registered in Systematic Reviews for Animals and Food and reported in accordance with PRISMA-ScR. We searched PubMed and Embase from 2015 onwards. Screening was conducted in two phases (title/abstract; full text) by one reviewer, with uncertainties resolved by a second reviewer. Data were charted on animal characteristics, CFA regimen details, welfare monitoring, reported local/systemic outcomes, analgesia/humane endpoints and comparator adjuvants. Of 1608 records screened, 689 were assessed at full-text level and 43 met inclusion criteria by reporting a welfare-relevant outcome (including ‘no adverse effects’): local outcomes were reported in 24/43 and systemic in 8/43; structured pain or behaviour monitoring occurred in 4/43 and formal scoring in 1/43 studies. Alternatives were evaluated in 32/43; in studies involving head-to-head comparisons with CFA (28/32), alternatives were more often better tolerated (22/28) than similar (6/28), with efficacy usually comparable or higher (31/32). Despite well-recognised welfare concerns with CFA, welfare-relevant outcomes are rarely reported. Standardised reporting of CFA regimens, welfare assessment methods and results is needed to support evidence-based refinement and comparison with alternatives.

Schlagwörter

Stichwörter der Autor:innen

Complete Freund’s adjuvantPRISMA-ScRadjuvantadverse effectsalternativesanimal welfareantibody productionimmunisationinjection-site reactionsrefinementscoping review

Autor:innen und Institutionen

  • Veterinary Public Health Institute, Vetsuisse Faculty, University of Bern, Switzerland.
  • Swiss Federal Food Safety and Veterinary Office, Bern, Switzerland.

ORCID-Profile: Valerie Hungerbühler, Agathe Verhulst, Cristian Berce, Beat Thomann, Luís Pedro Carmo

Förderung

  • Swiss Federal Food Safety and Veterinary Office

Zitieren

APA

Hungerbühler, V., Verhulst, A., Berce, C., Maissen, O., Thomann, B., & Carmo, L. P. (2026). Complete Freund’s adjuvant in laboratory animals: Reported welfare-relevant outcomes and alternatives—a scoping review. Laboratory Animals. https://doi.org/10.1177/00236772261459546

Vancouver

Hungerbühler V, Verhulst A, Berce C, Maissen O, Thomann B, Carmo LP. Complete Freund’s adjuvant in laboratory animals: Reported welfare-relevant outcomes and alternatives—a scoping review. Laboratory Animals. 2026. doi:10.1177/00236772261459546

BibTeX
@article{Hungerbhler2026,
  author = {Hungerbühler, Valerie and Verhulst, Agathe and Berce, Cristian and Maissen, Otto and Thomann, Beat and Carmo, Luís Pedro},
  title = {Complete Freund’s adjuvant in laboratory animals: Reported welfare-relevant outcomes and alternatives—a scoping review},
  journal = {Laboratory Animals},
  year = {2026},
  doi = {10.1177/00236772261459546}
}
Kostenlos starten →